View Points

This Ophthalmology Times Viewpoints series, moderated by Kendall Donaldson, MD, MS, and featuring panelists Cecelia Koetting, OD, FAAO; Selina McGee, OD, FAAO; and Karl Stonecipher, MD, explores innovative strategies for improving dry eye disease (DED) management. The discussion emphasizes the importance of sustained tear production as a therapeutic goal, reviews diagnostic and treatment distinctions, examines the efficacy of emerging therapies such as perfluorohexyloctane (Miebo), cyclosporine (Vevye), and acoltremon (Tryptyr), and concludes with practical advice on integrating new options into clinical practice to enhance long-term patient outcomes.

Experts discuss the diagnosis and treatment of dry eye disease when patients present with other ocular conditions or are preparing for cataract surgery.

Experts discuss the prevalence of dry eye disease (DED), their diagnostic and therapeutic approaches, as well as new FDA-approved and emerging treatments for DED.

Eyecare professionals examine the emerging role of miotic agents as promising treatment options for the management of patients with presbyopia.

A panel of ophthalmologists and optometrists discuss the significance of addressing dry eye disease using various types of treatment strategies, including pharmacologic and non-pharmacologic options.

Considerations in diagnosis, management, and upcoming treatments for patients.

A panel of experts in ophthalmology and optometry review the diagnosis and treatment of diabetic eye disease including emerging agents in the field.

Marguerite McDonald, MD, Eric Donnenfeld, MD, Tracy Swartz, OD, MS, FAAO, and Crystal Brimer, OD, FAAO, discuss a number of topics pertaining to Dry Eye including the diagnosis and clinical manifestations, traditional, treatment options, and the potential new agents in the horizon.

The ViewPoints Series is an interactive learning module featuring leading industry experts from across the eyecare spectrum. The series leverages the various perspectives of panel participants to create a meaningful conversation on a range of eye health topics and issues related to current clinical data and industry trends.